A B S T R A C T Tryptophol (3-indole ethanol) is a compound which induces sleep, and is formed: (a) in the liver after disulfiram treatment, and (b) by the parasite in trypanosomal sleeping sickness. We prepared, purified, and characterized radiolabeled tryptophol for the purpose of defining its tissue distribution in animals. Tryptophol was found to be highly lipophilic, with an octanol: water partition coefficient of 29.8. Brain extraction, determined after intracarotid injection, was high (brain uptake index = 117+3.5%), and nonsaturable, suggesting the absence of a carrier system. After intravenous administration, tryptophol distribution to tissues correlated with relative blood flow. More than 85% of the radioactivity remaining in brain 2-5 min after intravenous injection co-migrated with tryptophol standards when analyzed by thin-layer chromatography. Other evidence suggested that tryptophol binds to serum and in vivo may be stripped from serum albumin and taken up by brain in a single capillary transit. Our study suggests that in states such as trypanosomal sleeping sickness or disulfiram treatment, remotely formed tryptophol gains ready access to brain (it is 100% cleared in a single capillary passage), and could thus cause somnolence.
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INTRODUCTION
The reduction of indole acetaldehydes to their respective alcohols was postulated in 1916 by Guggenheim and Loffler (1) . Tryptophol was isolated as a tryptophan metabolite of yeast by Ehrlich in 1912 (2) and first identified from mammals as a tryptamine metabolite in rabbit liver (1) . Subsequently, 5-hydroxytryptophol was identified as a serotonin (5-hydroxytryptamine) metabolite in rats (3, 4) , bovine pineals (5) , and humans, both in vivo (6) and in brain tissue in vitro (7) . Ethanolinduced modification of the metabolism of biogenic indole amines results in the increased production of tryptophol compounds, specifically 5-hydroxytryptophol (4, (8) (9) (10) (11) (12) (13) . Disulfiram (Antabuse, Ayerst Laboratories, New York) treatment in rats induces the formation of tryptophol (14) and increased quantities of 5-hydroxytryptophol (10) .
Tryptophol compounds are known to induce sleep in laboratory mammals (15, 16) and chicks (17) . In the latter study, Taborsky (17) selected young chickens believing that because the adult blood brain barrier (BBB)1 specifically excluded central nervous system-(CNS) active substances such as tryptophol, it would be appropriate to use 1-14-d-old chicks. These young animals were believed to have an incomplete BBB (on the basis of electroencephalographic studies), and it was postulated that under these conditions penetration of tryptophols would be observed.
Stibbs and Seed (18, 19) demonstrated that Trypanosoma brucei gambiense, a blood parasite that causes trypanosomal sleeping sickness, converts tryptophan into two metabolites, indole lactic acid and indole ethanol (tryptophol). In addition to having immunosuppressive qualities (20) , current evidence suggests tryptophol is responsible for the sleep syndrome characteristic of the disease (18, 19) . Vogel (21) reported that 5-methoxytryptamine did not readily cross the BBB, and this precipitated the suggestion (22) that tryptophol compounds such as 5-methoxytryptophol may not cross 'Abbreviations used in this paper: BBB, blood brain barrier; BSA, bovine serum albumin; BUI, brain uptake index; CNS, central nervous system; Kd, dissociation constant; MBD, mean body distribution; Rf, retention ratio (relative to the solvent front); TLC, thin-layer chromatography. the BBB. Stibbs and Seed (18) consequently suggested that tryptophol formed by trypanosomes which had invaded the cerebrospinal fluid was responsible for the sleep syndrome associated with the disease.
In this study we have prepared radiolabeled tryptophol for the purpose of defining brain uptake in vivo after intracarotid injection, and for determining the distribution of this compound to various body tissues after intravenous administration in the rat.
METHODS
Tryptophol was purchased from Sigma Chemical Co. (St. Louis, Mo.). A 300-mg sample was commercially tritiated (Biochemical Nuclear Corporation, Burbank, Calif.) by the Wilzbach method. The tritiated compound was repeatedly washed to remove labile tritium, charcoal filtered, and purified by chromatographic separation on preparative silica gel plates in a benzene:acetic acid:water (172:25:3) solvent system (18) .
The purified tryptophol was dissolved in methanol or in pure (200-proof) Liquid scintillation counting. As soon as the tissue had been digested with an organic base (Soluene-100, Packard Instrument Co., Inc., Downers Grove, Il.) 10 ml of scintillation fluid, Instagel, (Packard Instrument Co., Inc.) was added to each vial and the pH of the solution brought to near neutrality by the addition of -75 ,l of acetic acid. The samples were counted for Indium content (1-min counts) in a Packard Tricarb 3390 scintillation counter with the windows set as described by Oldendorfand Szabo (25) . Days later, after all the 113m-Indium (t,,2 = 100 min) had decayed, the vials were total tritium dpmii injected/ total rat wt Simiiilarly, in this study, tissue:plasma (T/P) ratios were determiinledl as previously descril)ed (26) fromi the ratio:
Net 'H dpmli/g (plasmia)) (16) also observed in mice that tryptophol produced a reduction in body temperature which was not significant at the 5% confidence level. When tryptophol was administered in a propylene glycol solution we observed a significant reduction in body temperature (1.61+0.5°C) 10 min after injection and also at 30 min after injection (2.22+0.94°C). In both instances, these changes were statistically significant (P < 0.01) as measured by Dunnett's (29) 
Brain uptake indices. The brain uptake index of a trace concentration of tryptophol (relative to butanol) was determined to be 117+3.5%. The addition of 1 or 10 mM unlabeled tryptophol to the injectate resulted in no consistent reduction in brain uptake ( Table I) , suggesting that tryptophol uptake is not accomplished by a saturable, carrier-mediated process.
The observation that the apparent BUI increases with time of decapitation (5 s < 15 s < 30 s) might be attributed to a relatively faster initial washout rate of butanol than tryptophol (Table I) . By 2-4 min, the relative concentrations of tryptophol and butanol approximate those seen 5 s after intracarotid injection, suggesting similar relative washout rates over this time period.
The apparent reduction in brain uptake of tryptophol when 50% normal rat serum is included in the injectate (Table I) suggested that tryptophol may bind to elements in serum. Confirmation of this possibility was sought by determining the dissociation constant (Kd) in vitro. After dialysis for 2 h at 37°C, 93.8% of the tryptophol remained bound to the BSA and 6.22% was free (Kd = 2.9 ,uM). Overnight dialysis (17 h) at 40C resulted in only 1.4% of the tryptophol being recovered in the unbound fraction, and a similarly low dissociation constant (Kd = 1.4 ,uM) was calculated.
When BSA was replaced by normal rat serum in simi- Trace concentration of tryptophol injected was <15 nM in both these intracarotid studies, and in intravenous distributions (Table II) . The high permeability of tryptophol (BUI >100%) in the BBB is demonstrated by comparison with nondiffusible and highly diffusible compounds. Butanol (the reference substance used in this study) is believed to be 100% cleared in a single capillary transit (50) . Water has a BUI (relative to butanol) of 85% (50), whereas the BUIs of ethanol (about 88%) and isopropanol (about 94%) are higher (24) . Nondiffusible substances have minimally low BUIs; e.g., tryptamine (about 9%) (50) , thiourea (about 4%), and dextran (about 1%) (51) . lar studies, 6.14% of the tryptophol was recovered from the unbound fraction after 2 h at 37°C, with 2.17% recovered unbound after 17 h at 4°C. Tissue distributions. As indicated in Table II , tissue distribution of tryptophol 2 min after intravenous injection seems to correlate with the relative blood flow to the tissues examined. For compounds which gain entry to tissues by virtue of their lipophilic properties, relative distribution would be expected to correlate with blood flow. This point is further emphasized in comparing distribution of a resting muscle (Rectus femoris) with that seen in active muscles (e.g., diaphragm, ventricular myocardium). In addition, tryptophol distribution in the CNS was highest in the midbrain, presumably because relative blood flow to the corpora quadrigemina is markedly elevated (30) . Lowest (3H) uptakes were seen in low blood flow regions (fat, skin, testis, and resting skeletal muscle). The liver and renal cortex displayed highest relative concentrations of tritium, and these two organs receive almost one half of the total cardiac output under resting conditions (31) . The Indium spaces (Table II) [16] [29.8 and 37.5, respectively] can be attributed to method differences.) This is consistent with the relationship described by Oldendorf (24) between partition coefficient and BBB penetration. Nicotine and imipramine, two highly lipophilic compounds, have brain uptake indices (determined relative to tritiated water, and without Indium correction) of 130%. Their uptakes relative to butanol would be 110% (BUI water x 0.85 = BUI butanol), quite comparable to the 117% value of tryptophol (see Table I ) suggesting tryptophol is nearly 100% cleared in a single brain circulatory passage. These data are consistent with the rapid onset of CNS effects (sleep induction) seen with tryptophol administration.
A second point worthy of emphasis is that once tryptophol gains access to the brain, it apparently binds, or is altered so that it is not readily washed out of the CNS. The appare-nt increase in brain uptake seen at 5, 15, 30, and 60 s after intracarotid injection of tryptophol (Table I) is presumably due to a slower washout of tryptophol from brain relative to the butanol reference.
The recovery of almost 90% of the brain radioactivity in the form of tryptophol at 2 and 5 min after intravenous injection further suggests that this compound is not rapidly metabolized by brain, and that the BBB may exclude peripherally formed tryptophol metabolites during this time period. Such a conclusion is apparently consistent with the recent study of Seed and Sechelski (32) , who found highest levels of tryptophol in brains at 5 min postinjection, and coincidentally observed the absence of detectable levels of indole acetic acid (a tryptophol catabolite) in brain at this time.
The apparently rapid alteration of [3H]tryptophol by the liver (only 24% of the radioactivity was recovered as tryptophol after 5 min), seems consistent with previous suggestions that the liver is one of the principal sites for degradation of indole alcohols and indole acetaldehydes (13 (Table I) was < 10%. These data seem to be best explained by the previous report (33) indicating that albumin-bound indole compounds may be stripped away from the albumin and penetrate the BBB in a single transcapillary passage. The role of albumin binding in relation to brain tryptophan (and other indole amine) levels is a controversial subject. European investigators suggest that brain tryptophan concentration is a function of free tryptophan levels in the plasma (34) (35) (36) . In contrast, American workers indicate that brain tryptophan concentrations correlate with total (free plus bound) plasma tryptophan levels (37, 38) . This study demonstrates that in the case ofthis indole alcohol (which does not gain access to brain via a carrier mediated transport system), brain uptake is minimally affected by serum binding phenomena and thus is a function of total plasma tryptophol levels.
The penetration of tryptophan, an essential amino acid and source of the indole nucleus, into most tissues is carefully regulated by transport mechanisms in the cell membrane. In the BBB, for example, tryptophan entry from both free and albumin bound sources is carefully regulated by these carrier systems (33, 39) . The biological effect of indole alcohols such as trypto-phol and 5-hydroxytryptophol may well be due to their failure to be excluded by living membranes (a function of lipid solubility). These indoles consequently escape regulation by carrier systems and this presumably produces an imbalance ofbiochemical events surrounding indole metabolism.
This study demonstrates that the tryptophol is 100% cleared by the CNS in a single capillary transit. Thus, any tryptophol that reaches the circulatory system will gain access to this site. With relationship to pathological conditions such as alcoholism (tryptophol has been identified as a component of wine and beer [40] ) and trypanosomal sleeping sickness, brain uptake oftryptophol will be directly proportional to the arterial concentration ofthis compound and blood flow to the brain. When tryptophol is formed in the liver, as in the Antabuse-treated rat (14) , at least 14% (the fraction ofcardiac output distributing to brain) ofthe amount released into the circulatory system will gain access to the brain (Table II) .
In Antabuse-treated humans who take alcohol, there is an initial acutely unpleasant reaction lasting from 30 min to several hours, followed by a period of sleep lasting for several hours (41) . Antabuse alone often induces sedation, and administration upon retiring is suggested for these patients (42) . Recent animal studies also indicate that barbiturate-induced sleeping time is increased by concomitant administration of disulfiram (43, 44) . Our studies and those of Smith and Wortis (14) collectively suggest the possibility that tryptophol formed in the liver and circulating to the brain might induce this period of sleep.
Furthermore, in trypanosomal sleeping sickness, tryptophol formed by circulating trypanosomes (as well as organisms in the CNS) could well be responsible for the tryptophol-induced soporific effects. Because indole ethanol and indole acetaldehyde compounds may be readily interconverted, the possibility that either of these two forms may be the biochemical moiety responsible for sleep induction is discussed by Feldstein (45) . The penetration oftryptophol in lymphoid tissues such as the thymus, spleen, and mesenteric lymph nodes is of interest with respect to the recent observations of tryptophol-induced immunosuppression (20) .
Tissue distributions of radioactive ['4C]5-methoxytryptophol have been studied (46) 1, 2, and 6 h after intraperitoneal administration. This compound is formed in the pineal gland from 5-hydroxytryptophol and reduces ovarian weight as well as decreasing estrus in maturing rats (47) . Delvigs et al. (46) suggest it is rapidly metabolized (as indicated by radioactivity in the urine), and additionally showed high levels in thyroid, adrenals, ovaries, and uterus. The possibility of systemic biotransformation in their studies cannot be overlooked. For this reason, and for other technical differences, further comparison between this study and that of Delvigs et al. (46) seemed unwarranted. In addition, one would predict that 5-methoxytryptophol would have a slightly lower partition coefficient in octanol:water and its brain uptake might consequently be reduced in comparison to tryptophol (48) . A discussion of effects of hydroxylation and methoxylation in reducing brain uptake of compounds with structural similarities to biogenic amines appears elsewhere (48) . Recent work indicates that serum concentrations of 5-methoxytryptophol correlate with levels measured in the pineal gland (49) , and thus 5-methoxytryptophol might be expected to gain ready access to brain (15, 49) .
This study raises the question as to whether the apparent effects of tryptophol seen in trypanosomal sleeping sickness, and in disulfiram-treated states result in identical or merely similar biochemical events. Because appropriate animal model systems are available for laboratory studies, the combined study ofthese two conditions could conceivably result in both an increased understanding of biochemical events attributable to tryptophol as well as employing comparative biochemistry to gain further insight into trypanosomiasis and alcoholism.
